醒脾解郁方对轻中度抑郁症肝郁脾虚证患者的临床疗效研究
Clinical effect of Xingpi Jieyu Formula on mild to moderate depression of liver depression and spleen deficiency pattern
查看参考文献21篇
|
文摘
|
目的研究醒脾解郁方对轻中度抑郁症肝郁脾虚证患者的临床疗效。方法选择2018年7月—2019年1月就诊于北京中医药大学东方医院的抑郁症肝郁脾虚证患者,共61例,按入组时间顺序编号,随机分为对照组30例和试验组31例,对照组给予中药安慰剂(醒脾解郁颗粒模拟剂),试验组给予醒脾解郁方配方颗粒。2组患者均每日服药1剂,上下午分服,共治疗6周,比较2组患者汉密尔顿抑郁量表( HAMD-24) 、汉密尔顿焦虑量表( HAMA) 、抑郁自评量表( SDS) 、焦虑自评量表( SAS) 、抑郁症中医证候要素量表分数变化情况,治疗前后外周血腺嘌呤核苷三磷酸( ATP) 、腺嘌呤核苷二磷酸( ADP) 、腺嘌呤核糖核苷酸( AMP)含量变化情况以及不良反应发生情况。结果临床疗效:与治疗前比较,对照组患者治疗后的HAMD-24总分以及焦虑/躯体化、认知障碍、日夜变化、阻滞、绝望感5类因子,SDS总分,中医证候气虚与气滞分数降低( P < 0.05);试验组患者治疗后HAMD-24总分以及焦虑/躯体化、睡眠障碍、认知障碍、日夜变化、阻滞、绝望感6类因子,胃肠道症状、全身症状2个单项因子,HAMA总分及躯体性焦虑、精神性焦虑2类因子,SDS总分,SAS总分,中医证候气虚、气滞、痰湿分数均下降( P < 0.05), HAMD-24评分总有效率为93.55 %(显效率为70.97 % ) 。在作用机制方面:与治疗前比较,对照组治疗后外周血AMP含量升高( P < 0.05);试验组治疗后外周血ATP含量升高( P < 0.05) 。安全性指标:对照组1例患者出现恶心,试验组2例患者出现腹泻,均在短期内自愈( 2 ~ 3 d),未出现肝肾功能损伤的病例。结论与中药安慰剂相比,醒脾解郁方可显著改善抑郁症患者抑郁情绪及躯体症状,且可以提高外周血ATP含量水平。 |
|
其他语种文摘
|
To study the effects of Xingpi Jieyu Formula on mild to moderate depression of liver depression and spleen deficiency pattern. Methods 61 patients with depression of liver depression and spleen deficiency pattern who volunteered to participate in the study from July 2018 to January 2019 were randomly divided into control group ( 30 cases) and experimental group ( 31 cases) according to the time sequence. The control group was treated with placebo ( Xingpi Jieyu granule simulant) and the experimental group was treated with Xingpi Jieyu formula granules. Both groups took 1 dose daily and took separately in the morning and afternoon After 6 weeks of treatment,HAMD-24,HAMA,SDS, SAS,TCM syndrome factor scale scores of depression were compared between the two groups,and the changes of ATP,ADP,amp contents in peripheral blood of the two groups before and after treatment, as well as the occurrence of adverse reactions were compared. Results In terms of clinical efficacy: compared with before treatment, the total scores of HAMD-24, five factor scores of “anxiety / somatization,cognitive impairment,day and night change,block and sense of despair”,SDS score,qi deficiency and qi stagnation pattern scores were reduced in the control group ( P < 0.05 ); the total scores of HAMD-24,six factor scores,gastrointestinal and general symptoms,HAMA total scores, somatic and psychological scores,SDS score,SAS score,and pattern scores of qi deficiency,qi stagnation and phlegm dampness were significantly lower than those before treatment in the experimental group ( P < 0.05 ). The total effective rate of HAMD score was 93.55% ( 70.97% markedly effective). In terms of mechanism of action: compared with before treatment,peripheral serum AMP increased in the control group ( P < 0.05); ATP increased in the experimental group after treatment ( P < 0.05 ); in terms of safety profile,1 patient in control group had nausea,and 2 patients in the experimental group had nausea diarrhea. All symptoms disappeared on its own shortly ( 2-3 days). No cases of liver and kidney injury. Conclusion Compared with placebo,Xingpi Jieyu Formula could significantly improve depression and somatic symptoms of depressive patients, and can increase peripheral blood ATP level. |
|
来源
|
北京中医药大学学报
,2021,44(1):83-91 【核心库】
|
|
DOI
|
10.3969/j.issn.1006-2157.2021.01.013
|
|
关键词
|
抑郁症
;
肝郁脾虚证
;
醒脾解郁方
;
线粒体
;
腺嘌呤核苷三磷酸
|
|
地址
|
1.
首都医科大学附属北京中医医院, 北京, 100010
2.
北京中医药大学东方医院
3.
北京中医药大学
4.
中国科学院心理研究所
5.
清华大学玉泉医院
|
|
语种
|
中文 |
|
文献类型
|
研究性论文 |
|
ISSN
|
1006-2157 |
|
学科
|
中国医学 |
|
基金
|
国家自然科学基金项目
|
|
文献收藏号
|
CSCD:6925331
|
参考文献 共
21
共2页
|
|
1.
高曌. 浅谈从肝论治抑郁症.
中国中医药现代远程教育,2017,15(8):53-54
|
CSCD被引
2
次
|
|
|
|
|
2.
尹冬青. 15196例抑郁症中医证候及证候要素特点的文献研究.
中华中医药学刊,2013,31(2):279-282
|
CSCD被引
14
次
|
|
|
|
|
3.
李德智. 抑郁症中医证候及证候要素分布特点的文献研究.
光明中医,2018,33(19):2781-2783
|
CSCD被引
7
次
|
|
|
|
|
4.
郭静. 醒脾开郁方抗抑郁的动物行为学研究.
中国中医基础医学杂志,2005(2):135-136
|
CSCD被引
2
次
|
|
|
|
|
5.
郭蓉娟. 抑郁症中医证候要素辨证量表研究.
北京中医药大学学报,2015,38(8):561-565
|
CSCD被引
7
次
|
|
|
|
|
6.
王晓涛. 安慰剂效应与安慰剂组学的研究与思考.
世界科学技术-中医药现代化,2016,18(12):2043-2048
|
CSCD被引
2
次
|
|
|
|
|
7.
Fuente-Fernandez R D L. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease.
Science,2001,293:1164-1166
|
CSCD被引
12
次
|
|
|
|
|
8.
翟阳. 舒肝饮治疗轻中度抑郁症的随机双盲安慰剂对照研究.
中西医结合心血管病杂志,2018,6(33):156
|
CSCD被引
1
次
|
|
|
|
|
9.
Cai N. Genetic Control over mt DNA and its relationship to major depressive disorder.
Curr Biol,2015,25(24):3170-3177
|
CSCD被引
4
次
|
|
|
|
|
10.
Zubenko G S. Differential hippocampal gene expression and pathway analysis in an etiology-based mouse model of major depressive disorder.
Am. J. Med. Genet. B Neuropsychiatr. Genet,2015,3:316
|
CSCD被引
1
次
|
|
|
|
|
11.
Clay H. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia.
Int J Dev Neurosci,2011,29(3):311-324
|
CSCD被引
5
次
|
|
|
|
|
12.
Karabatsiakis A. Mitochondrial respiration in peripheral blood mononuclear cells correlates with depressive subsymptoms and severity of major depression.
Translat Psychiatry,2014:6
|
CSCD被引
7
次
|
|
|
|
|
13.
Che Y. Chronic unpredictable stress impairs endogenous antioxidant defense in rat brain.
Neuroscience letters,2015,584:208-213
|
CSCD被引
3
次
|
|
|
|
|
14.
Ben-Shachar D. Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression.
PLoSOne,2008,11
|
CSCD被引
7
次
|
|
|
|
|
15.
Yuan Q J. Effects of XingPiJieYu Decoction on ATP,Na/K-ATPase and respiratory chain complexes of hippocampus and gastrocnemius muscle in depressed rats.
Evidence-Based Complementary and Alternative Medicine,2019,1
|
CSCD被引
1
次
|
|
|
|
|
16.
袁清洁. 基于皮质酮-炎性反应-线粒体网络研究抑郁症肝郁脾虚病机及醒脾解郁方干预效应.
中华中医药杂志,2017,32(5):2241-2245
|
CSCD被引
15
次
|
|
|
|
|
17.
史华伟. 醒脾解郁方对抑郁大鼠行为学及海马与骨骼肌线粒体超微结构的影响.
北京中医药大学学报,2017,40(4):284-289
|
CSCD被引
7
次
|
|
|
|
|
18.
韩胜斌. 醒脾解郁法对抑郁大鼠肝脏能量代谢的调控机制研究.
环球中医药,2018,11(12):1862-1866
|
CSCD被引
8
次
|
|
|
|
|
19.
马涛. 慢性应激对大鼠脾脏能量代谢及细胞免疫功能损伤和醒脾解郁法的干预机制研究.
环球中医药,2019,12(3):321-327
|
CSCD被引
4
次
|
|
|
|
|
20.
李阳. 醒脾解郁方对CUMS抑郁模型大鼠血清IL-8及肝脏MDA、mtDNA、ATP含量水平的影响.
环球中医药,2019,12(4):497-501
|
CSCD被引
1
次
|
|
|
|
|
了解气象卫星更多信息，请访问